Global Cardiovascular Devices Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Cardiovascular devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Cardiovascular devices market growth, size, share, trends and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global cardiovascular devices market size reached US$ 55.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Cardiovascular devices encompass a diverse array of specialized medical instruments intended for the diagnosis, treatment, or management of heart and blood vessel-related conditions. These devices are surgically placed within the body to address various cardiac ailments. They hold a pivotal position in contemporary healthcare, empowering medical practitioners to deliver efficacious treatments and enhance the well-being of individuals grappling with cardiovascular illnesses.
Global Cardiovascular Devices Market Trends and Drivers:
The escalating incidence of heart failure, largely driven by the increasing prevalence of cardiovascular diseases (CVDs), stands as a significant catalyst for the global demand for cardiovascular devices. This surge can also be attributed to sedentary lifestyles, unhealthy dietary habits, heightened stress levels, the prevalence of diabetes, and rising obesity rates among the general population. Furthermore, the expanding elderly demographic, which is more susceptible to medical conditions, coupled with substantial enhancements in healthcare infrastructure, is fostering market expansion. Additionally, the growing preference for minimally invasive surgeries (MIS), owing to their associated advantages, is further boosting market growth. Moreover, the integration of cutting-edge technologies such as artificial intelligence (AI), machine learning (ML), predictive analytics, sensors, and advanced algorithms for early heart disease detection, faster stroke treatment, and improved diagnostic radiology capabilities, is making significant contributions to market growth. Furthermore, increased investments in research and development (R&D) activities by key industry players are propelling market expansion.
Global Cardiovascular Devices Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG) and Terumo Cardiovascular Systems Corporation (Terumo Corporation)
The report segmented the market on the basis of region, device type, application and end user.
Breakup by Device Type:
- Diagnostic and Monitoring Devices
- Electrocardiogram (ECG)
- Remote Cardiac Monitoring
- Others
- Therapeutic and Surgical Devices
- Cardiac Rhythm Management (CRM) Devices
- Catheter
- Stents
- Heart Valves
- Others
Breakup by Application:
- Coronary Artery Disease (CAD)
- Cardiac Arrhythmia
- Heart Failure
- Others
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800